Insights

Advanced AI Platform Verge Genomics employs a proprietary all-human CONVERGE platform and extensive multi-omic patient data, making it highly attractive to pharmaceutical companies and biotech firms seeking state-of-the-art drug discovery solutions for neurodegenerative diseases.

Strategic Partnerships The company's collaborations with giants like Eli Lilly, AstraZeneca, and Stem Pharm demonstrate a strong interest from leading industry players in leveraging Verge's AI-driven insights, opening opportunities for joint ventures or licensing agreements.

Focus on Neurodegeneration With ongoing clinical and preclinical programs targeting ALS and Parkinson's disease, Verge presents a compelling option for organizations aiming to expand their pipeline in neurodegenerative medicine, especially those seeking innovative approaches to complex diseases.

Funding & Growth Potential Backed by significant funding of over $134 million and revenue estimates up to $50 million, Verge Genomics is positioned for growth and could be a valuable partner for investors or service providers targeting expanding biotech enterprises.

Research and Development Opportunities The company's focus on validating novel targets and developing disease models aligns with the needs of firms specializing in biomarker discovery, diagnostic tools, or personalized medicine, offering potential sales channels for research collaborations or technology licensing.

Verge Genomics Tech Stack

Verge Genomics uses 8 technology products and services including Linkedin Insight Tag, RSS, Jupyter, and more. Explore Verge Genomics's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • RSS
    Content Management System
  • Jupyter
    File Sharing
  • Flickity
    Javascript Libraries
  • scikit-learn
    Machine Learning
  • Priority Hints
    Performance
  • HTML
    Programming Languages
  • YouTube
    Video Players

Media & News

Verge Genomics's Email Address Formats

Verge Genomics uses at least 1 format(s):
Verge Genomics Email FormatsExamplePercentage
First@vergegenomics.comJohn@vergegenomics.com
77%
First.Last@vergegenomics.comJohn.Doe@vergegenomics.com
14%
Last@vergegenomics.comDoe@vergegenomics.com
7%
First.MiddleLast@vergegenomics.comJohn.MichaelDoe@vergegenomics.com
2%

Frequently Asked Questions

What is Verge Genomics's phone number?

Minus sign iconPlus sign icon
You can contact Verge Genomics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Verge Genomics's official website and social media links?

Minus sign iconPlus sign icon
Verge Genomics's official website is vergegenomics.com and has social profiles on LinkedInCrunchbase.

What is Verge Genomics's SIC code NAICS code?

Minus sign iconPlus sign icon
Verge Genomics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Verge Genomics have currently?

Minus sign iconPlus sign icon
As of December 2025, Verge Genomics has approximately 51 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Vice President And Head Of Translational Medicine: A. T.Head Of Bioinformatics: G. B.Executive Assistant To The Chief Business Officer And Chief Science Officer: A. T.. Explore Verge Genomics's employee directory with LeadIQ.

What industry does Verge Genomics belong to?

Minus sign iconPlus sign icon
Verge Genomics operates in the Biotechnology Research industry.

What technology does Verge Genomics use?

Minus sign iconPlus sign icon
Verge Genomics's tech stack includes Linkedin Insight TagRSSJupyterFlickityscikit-learnPriority HintsHTMLYouTube.

What is Verge Genomics's email format?

Minus sign iconPlus sign icon
Verge Genomics's email format typically follows the pattern of First@vergegenomics.com. Find more Verge Genomics email formats with LeadIQ.

How much funding has Verge Genomics raised to date?

Minus sign iconPlus sign icon
As of December 2025, Verge Genomics has raised $134M in funding. The last funding round occurred on Dec 16, 2021 for $98M.

When was Verge Genomics founded?

Minus sign iconPlus sign icon
Verge Genomics was founded in 2015.

Verge Genomics

Biotechnology ResearchCalifornia, United States51-200 Employees

Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data. Verge is focused on developing therapeutics for complex diseases with high unmet need, using human genomics from patient disease tissues and machine learning. Verge has created a proprietary all-in-human CONVERGE® platform, featuring one of the field’s largest and most comprehensive databases of multi-omic patient data. 

The company is led by experienced computational biologists and drug developers who are successfully advancing clinical and preclinical therapeutic programs in various diseases, including ALS and Parkinson’s disease. 

Verge actively seeks a diverse applicant pool in order to build the strongest possible workforce. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $134M

    Verge Genomics has raised a total of $134M of funding over 3 rounds. Their latest funding round was raised on Dec 16, 2021 in the amount of $98Mas a equity financing.

  • $25M$50M

    Verge Genomics's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $134M

    Verge Genomics has raised a total of $134M of funding over 3 rounds. Their latest funding round was raised on Dec 16, 2021 in the amount of $98Mas a equity financing.

  • $25M$50M

    Verge Genomics's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.